Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by Gore & Associates

evt | Article | September 2012 Supplement

Intricacies of Isolated Lesions

With technological developments comes new focus on isolated lesions, but what exactly are they?

By William Jordan, MD, and Mark Farber, MD, FACS

Sponsored by Gore & Associates

evt | Article | March 2016 Supplement

Long-Term Data Supporting the Conformable GORE® TAG® Thoracic Endoprosthesis in DTA Pathologies

An overview of the recent data that confirm positive results when using this device to treat both acute and chronic conditions of the descending thoracic aorta.

By Mark A. Farber, MD; Richard Cambria, MD; and William Jordan, MD

evt | News | November 15, 2018

Three-Year Data From ANCHOR Registry Presented for Medtronic's Heli-FX EndoAnchor System

November 16, 2018—Medtronic announced the presentation of data on the Heli-FX EndoAnchor system by William Jordan Jr, MD, at the 45th annual VEITHsymposium held November 13–17 in New York, New York.

Sponsored by Gore & Associates

evt | Article | February 2012 Supplement

Optimizing Clinical Outcomes for Thoracic Aneurysms

The variability of treatment diameters with the new Conformable GORE® TAG® Device offers improved management for a wide variety of patients.

By William D. Jordan Jr, MD

Advertisement

Advertisement

evt | News | July 9, 2019

Gore's TAG Conformable Thoracic Stent Graft With Active Control System Launched in the United States

July 10, 2019—Gore & Associates announced the commercial launch in the United States of the company's TAG conformable thoracic stent graft with Active Control system, with the first implantation of the device performed by William Jordan, MD, from Emory University School of Medicine in Atlanta, Georgia.

evt | Article | August 2018

Residual Dissection and False Lumen Aneurysm After TEVAR

Moderator: Mark Farber, MD
Panel: Yazan Duwayri, MD; Matthew J. Eagleton, MD; William D. Jordan Jr, MD; Tilo Kölbel, MD, PhD; and Eric L.G. Verhoeven, MD, PhD

evt | News | October 31, 2009

Conformable Gore TAG Device Used in IDE Trial

October 20, 2009—W.

evt | News | October 19, 2009

First Implants Performed in Trial of Next-Generation Conformable Gore TAG Device

October 20, 2009—W.L.

evt | News | July 19, 2021

Endologix ChEVAS System Receives FDA Breakthrough Device Designation

July 19, 2021—Endologix LLC announced that the company’s chimney endovascular aneurysm sealing (ChEVAS) system, has been granted a Breakthrough Device designation from the FDA.

evt | Article | July 2012

Innovations

A preview of today's new products

evt | News | October 8, 2017

FDA Approves Indication for Medtronic Endurant II/IIs Stent Graft System to Treat Short-Neck Anatomies

October 9, 2017—Medtronic announced that it has received US Food and Drug Administration (FDA) approval for the Endurant II/IIs stent graft system to treat abdominal aortic aneurysm (AAA) patients with neck lengths down to 4 mm and ≤ 60° infrarenal angulation when used in combination with the Heli-FX EndoAnchor system.

Sponsored by Medtronic

evt | Article | November 2018

Rethinking EVAR: Is Longer Seal Zone the Only Answer for Enhancing Durability?

Mimicking an interrupted anastomosis via an endovascular approach.

By Ross Milner, MD, FACS

Sponsored by Medtronic

evt | Article | August 2022

The Current Landscape of EndoSuture Aneurysm Repair (ESAR)

A physician-led discussion on the use of ESAR in the treatment of AAA.

With Naiem Nassiri, MD, FSVS, RPVI; Julia Fayanne Chen, MD, MPH; William D. Jordan Jr, MD; Ross Milner, MD, FACS; Apostolos K. Tassiopoulos, MD, FACS; and Brant W. Ullery, MD, FACS

evt | News | November 15, 2011

FDA Approves Conformable Gore TAG Thoracic Endoprosthesis

November 16, 2011—Gore & Associates (Flagstaff, AZ) announced that it has received approval from the US Food and Drug Administration to market the Conformable Gore TAG thoracic endoprosthesis as a minimally invasive treatment of thoracic aortic aneurysms.

evt | News | December 11, 2017

Medtronic's Endurant II/IIs System With Heli-FX EndoAnchor System Granted CE Mark Approval for Indication to Treat Short-Neck Anatomies

December 12, 2017—Medtronic announced that it has received European CE Mark approval for its Endurant II/IIs stent graft system to treat abdominal aortic aneurysm patients with neck lengths as small as 4 mm and ≤ 60° infrarenal angulation when used in combination with the Heli-FX EndoAnchor system.

evt | News | November 21, 2019

Medtronic Presents 1-Year Valiant Navion and 4-Year ANCHOR Registry Outcomes

November 22, 2019—Medtronic announced the presentation of 1-year outcomes for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR) and 4-year clinical outcomes from the ANCHOR registry evaluating the company’s Heli-FX EndoAnchor system in patients with hostile neck abdominal aortic aneurysms (AAAs) at the VEITHsymposium held November 19–23 in New York, New York.

evt | News | February 13, 2012

ANCHOR Postmarket Registry Will Evaluate Aptus' HeliFX

February 14, 2012—Aptus Endosystems, Inc. (Sunnyvale, CA) announced the start of the ANCHOR postmarket registry, which will evaluate the use of the company's HeliFX aortic securement system.

evt | News | February 13, 2012

ANCHOR Postmarket Registry Will Evaluate Aptus' HeliFX

February 14, 2012—Aptus Endosystems, Inc. (Sunnyvale, CA) announced the start of the ANCHOR postmarket registry, which will evaluate the use of the company's HeliFX aortic securement system.

evt | News | May 30, 2013

Three-Year Clinical Data Presented for Endurant AAA Stent Graft

May 31, 2013—New data on the Endurant abdominal aortic aneurysm (AAA) stent graft system (Medtronic, Inc., Minneapolis, MN) were presented at the Society for Vascular Surgery's Vascular Annual Meeting being held in San Francisco, California.

evt | News | November 16, 2016

Medtronic's Heli-FX EndoAnchor System Yields Positive Results for Patients With Hostile Aortic Neck Anatomy

November 17, 2016—Medtronic announced a series of new data on its Heli-FX EndoAnchor system that show enhanced outcomes and durability in patients with complex aortic abdominal aneurysm (AAA) anatomy, particularly those who have hostile aortic neck anatomy.


1
2

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button